Presentation on Beximco Pharmaceuticals Name of the presenters ~ Faisal Bin Kamal 2009-3-10-057 2010-1-10-145 2010-1-10-149 2010-1-40-052 ~ Quazi Aritra Reyan ~ Md. Nayeem Hossain ~ Tahrim Shahriar Background of the Company Beximco Pharmaceuticals (BPL) is a leading edge pharmaceutical company based in Dhaka‚ Bangladesh. BPL started its operation in 1980 and now have grown to become nation’s one of the leading pharmaceutical companies. ~ BPL supplies more than 10% of country’s
Premium Pharmaceutical industry Tax Balance sheet
patients” (Abraham 2010:604). According to Abraham (2010)‚ pharmaceuticalization is currently on an upward spiral and this dramatic increase can be attributed to five different factors. These five explanations are biomedicalism‚ medicalization‚ pharmaceutical industry promotion and marketing‚ consumerism‚ and regulatory-state ideology or policy. Each of these explanatory factors are mutually interactive but competing and it will be explained how this is in the following paragraphs. The biomedicalization
Premium Attention-deficit hyperactivity disorder Pharmacology Medicine
Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial
Product‚ Process‚ and Service: A New Industry Lifecycle Model Michael Cusumano MIT Sloan School of Management 50 Memorial Drive‚ E52-538 Cambridge‚ MA 02142-1347 USA 617-253-2574 cusumano@mit.edu Fernando F. Suarez Boston University School of Management 595 Commonwealth Ave.‚ Room 546-F Boston‚ Massachusetts 02215‚ USA 617-358-3572 suarezf@bu.edu Steve Kahl MIT Sloan School of Management 50 Memorial Drive‚ E52-511 Cambridge‚ MA 02142-1347 USA 617-253-6680 skahl@mit.edu March 8‚ 2007
Premium Technology Economy Innovation
Beximco Pharmaceutical Ltd is the manufacturer and marketer of pharmaceutical product under chemical divisions of Beximco Group. Beximco Pharmaceuticals is one of the leading pharmaceutical companies in Bangladesh. It also is one of the biggest suppliers of pharmaceutical product of any Bangladeshi based company. BPL is the first Bangladeshi company to supply pharmaceutical product to Riffles Hospital the most prestigious hospital of Singapore. The study has been carried out with the following objectives:
Premium Marketing Pharmaceutical industry Pharmacology
Introduction In 1973‚ the UK based multinational pharmaceutical company‚ ICI plc. Established a subsidiary in Dhaka‚ known as ICI Bangladesh Manufacturers Limited. In 1992‚ ICI plc. divested its share to local management‚ and the company was renamed Advanced Chemical Industries (ACI) Limited. ACI formulates and markets a comprehensive range of more than 387 products covering all major therapeutic areas‚ which come in tablet‚ capsule‚ powder‚ liquid‚ cream‚ ointment‚ gel ‚ophthalmic and injection
Premium ISO 9000 Quality management Quality assurance
brands‚ but also within beverage types. Wine consumption in Canada has been increasing substantially. Consumers are always looking for something new and exciting‚ but at the same time‚ something they can relate to. “A key point for success is to bring differentiation while still retaining a recognizable and familiar aspect”(t). Another obstacle the brewing industry is facing is the wrong perception consumers have about beer and its effect on weight and overall health. “Beer belly”‚ for example is just
Premium Beer
Questions for Review 1. Pharmaceutical companies do have a responsibility to distribute drugs for a low cost in developing and poorer countries. Africa’s GDP‚ and per capita income is very low so they cannot afford to buy top quality medicines. One main argument for this approach is the AIDS epidemic in Africa. A main argument against this is that the treatment for AIDS is very expensive to provide to a whole country for free. 2. The principal arguments of pharmaceutical companies that oppose making
Premium HIV World Trade Organization Pharmacology
ENVIRONMENTAL FACTORS AFFECTING INDUSTRY 1 I.1. PESTEL ANALYSIS 1 I.2. FIVE FORCES MODEL 3 II. IMPLICATIONS OF CHANGING BUSINESS ENVIRONMENT 4 III. USE AND LIMITATIONS OF TOOLS APPLIED 5 III.1. USE AND LIMITATIONS OF PESTEL 5 III.2. USE AND LIMITATIONS OF FIVE FORCES MODEL 6 SUMMARY 6 APPENDIX 1 8 APPENDIX 2 9 REFERENCES 10 INTRODUCTION The origin of the modern pharmaceutical industry can be traced to the late
Premium Strategic management Pharmaceutical industry Generic drug
antidiabetics such as Glucophage‚ and the anti-clotting medication‚ Plavix. To continue to focus on pharmaceuticals‚ in the early years of 2000-2002‚ the company divested many of their non-pharmaceutical divisions‚ such as Clairol and the Mead-Johnson Nutritional division‚ and purchased DuPont Pharmaceuticals as well as an almost 20% share of ImClone Systems‚ which was getting ready to release a new anti-cancer drug‚ Erbitux (SEC eyes Bristol-Myers‚ 2002). In April of 2002‚ the trouble for BMS began
Premium Revenue Marketing Inventory